Prostate cancer gene

Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 6, 536 241, 536 2431, 536 2432, 536 2433, 536 243, C07H 2102, C07H 2104, C12Q 168

Patent

active

059455225

ABSTRACT:
The present invention relates to PG1, a gene associated with prostate cancer. The invention also relates to methods of determining whether an individual is at risk for developing prostate cancer at a later date or whether an individual suffers from prostate cancer as a result of a mutation in the PG1 gene.

REFERENCES:
patent: 5807680 (1998-09-01), Sutcliffe et al.
human genome and its expression!", C R Acad sci III, 318(2) pp. 263-2721 (Feb. 1995).
Ashagbley, et al., "Synthesis of Ether-Linked Analogues of Lysophosphatidate and their Effect on the Proliferation of Human Epithelial Cancer Cells", Anticancer Research, 16(4A): 1813-1818 (1996).
Coleman, J., "Characterizaiton of the Escherichia coli gene for 1-acyl-sn-glycerol-3-phosphate acyltransferase (plsC)", Mol. Gen. Genet, 232(2) :295-303 (1992).
Chumakov, et al., "A YAC contig map of the human genome", Nature, 377 Supp : 175-297 (1995).
Durieux, et al., "Signalling properties of lysophosphatidic acid", Trends in Pharmacol. Sci., 14(6) : 249-254 (1993).
Eberhardt, et al., "Human Lysophosphatidic Acid Acyltransferase", J. Biol. Chem. 272(32) : 20299-20305 (1997).
Emi, et al., "Frequent Loss of Heterozygosity for Loci on Chromosome 8p in Hepatocellular Carcinoma, Colorectal Cancer, and Lung Cancer", Cancer Research, 52(19) : 5368-5372 (1992).
Faas, et al., "Increased phospholipid fatty acid remodeling in human and rat prostatic adenocarcinoma tissues", J. Urol (Baltimore), 156(1): 243-248 (1996).
Gronwald, et al., "Comparison of DNA Gains and Losses in Primary Renal Clear Cell Carcinomas and Metastatic Sites: Importance of 1q and 3p Copy Number Changes in Metastatic Events", Cancer Research, 57(3) : 481-487 (1997).
Gu, et al., "Identification cloning, and expression of a cytosolic megakaryocyte protein-tyrosine-phosphatase with sequence homology to cytoskeletal protein 4.1", Proc. Natl. Acad. Sci. USA, 88(13)): P5867-71 (1991).
Hsuan, et al., "Growth Factor-dependent Phosphoinositide Signalling", Int. J. Biochem. Cell. Biol., 29(3) : 415-435 (1997).
Ichikawa, et al., "*"Prostate Suppl., 6 : 31-35 (1996).
Kume, et al., "cDNA Cloning and Expression of Murine 1-Acyl-sn-glycerol-3-phosphate Acyltransferase", Biochemical and Biophysical Research Communications, 237(3) : 663-666 (1997).
Levine, et al., "Lysophosphatidic acid: a novel growth and survival factor for renal proximal tubular cells", American Physiological Society, 273(4PT2) : F575-F585 (1997).
Martin, T.F.J., "Phosphoinositides as spatial regulators of membrane traffic", Curr. Opin. Neurobiol., 7(3) : 331-338 (1997.
Matsuyama, et al., "Deletion mapping of chromosome 8p in prostate cancer by fluorescense in situ hybridization", Oncogene, 9(10 :3071-3076 (1994).
Nagai, et al., "Comprehensive allelotyping of human hepatocellular carcinoma", Oncogene, 14(24) :2927-2933 (1997).
Nagiec, et al., "A Suppressor Gene That Enables Saccharomyces cerevisiae to Grow without Making Sphingolipids Encodes a Protein That Resembles an Escherichia coli Fatty Acyltransferase", Journal of Biological Chemistry, 268(29) : 22156-22163 (1993).
Qi C, et al., "Lysophosphatidic acid stimulates phospholipase D activity and cell proliferation in PC-3 human prostate cancer cells", J. Cell. Physiol., 174(2) : 261-272 (1998).
Scholnick, et al., "Chromosome 8 Alleic Loss and the Outcome of Patients With Squamous Cell Carcinoma of the Supraglottic Larynx", Journal of the National Cancer Institute, 88(22) : 1676-1682 (1996).
Sunkara, et al., A novel class of low molecular weight (MW) phospholipid (PL) signaling inhibitors is selectively cytotoxi for tumor cells (Meeting abstract): & Proc Annu Meet Am Assoc Cancer Res, 35: A2441 (1994).
Sunwoo, et al., "Evidence of Multiple Tumor Suppressor Genes on Chromosome Arm 8p in Supraglottic Laryngeal Cancer", Genes, Chromosomes & Cancer, 16 :167-169 (1996).
Toker, et al., "Signalling through the lipid products of phosphoinositid-3-OH kinase", Nature, 387 : 673-676 (1997).
Washburn, et al., "Deletion of loci mapping to 8p23-pter in human prostate cancers", Proceedings of the American Association for Cancer Research, 38(#3456) : 515 (Mar. 1997).
Wilson, et al., "2.2 M6 of contiguous nucleotide sequence from chromosome III of C. elegans", Nature 368(6466): P32-38 (1994).
Yaremko, et al., :Deletion Mapping Reveals Two Regions of Chromosome 8 Allele Loss in Colorectal Carcinomas, Genes, Chromosomes & Cancer, 10 : 1-6 (1994).
SwissProt: P26647, date Nov. 1, 1998.
SwissProt: P33333, date Nov. 1, 1998.
SwissProt: P38226, date Nov. 1, 1997.
Genbank Accession No. Z29518, date Nov. 12, 1994.
Genbank Accession No. AB005623, date Oct. 6, 1997.
Genbank Accession No. U56417, date Jun. 4, 1997.
Genbank Accession No. U89336, date Feb. 15, 1997.
Genbank Accession No. Z49860, date Jan. 6, 1996.
Genbank Accession No. Z49770, date Aug. 11, 1997.
Genbank Accession No. Z72511, date Sep. 21, 1998.
Genbank Accession No. AF003136, date Dec. 31, 1997.
Search Report listing sequence EMEST7, Accession No. AA280082.
Public Database Chart.
Patented Sequences Database Chart.
West et al, "Cloning and expression of two human lysophosphatidic acid acyltransferase cDNAs that enhance cytokine-induced signaling responses in cells", DNA Cell Biol. 16(6):691-701, Jun. 1997.
Bender et al, Genbank Locus MUSPHKGZ, Accession No. L08057, Sep. 1995.
Hillier et al, Genbank Locus AA056643, Accession No. AA056643, May 1997.
Auffray et al, Genbank Locus HSC2CG051, Accession No. Z45294, Sep. 1995.
Hillier et al, Genbank Locus WO1144, Accession No. WO1144, Apr. 1996.
Auffray et al, Genbank Locus HSC2E00111, Accession No. Z44999, Sep. 1995.
Stratagene Catalog, pp. 62-63, 1995.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Prostate cancer gene does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prostate cancer gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostate cancer gene will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2426726

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.